Medistim ASA Financials
| MEDI Stock | NOK 154.00 0.50 0.32% |
Medistim |
Understanding current and past Medistim ASA Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Medistim ASA's financial statements are interrelated, with each one affecting the others. For example, an increase in Medistim ASA's assets may result in an increase in income on the income statement.
Medistim ASA Stock Summary
Medistim ASA competes with Bergenbio ASA, Aega ASA, and Saga Pure. Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway. MEDISTIM ASA operates under Medical Equipment classification in Norway and is traded on Oslo Stock Exchange. It employs 105 people.| Foreign Associate | USA |
| Instrument | Norway Stock View All |
| Exchange | Oslo Stock Exchange |
| ISIN | NO0010159684 |
| Business Address | kernveien 94, Oslo, |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | www.medistim.com |
| Phone | 47 23 05 96 60 |
| Currency | NOK - Kroner |
You should never invest in Medistim ASA without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Medistim Stock, because this is throwing your money away. Analyzing the key information contained in Medistim ASA's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Medistim ASA Key Financial Ratios
There are many critical financial ratios that Medistim ASA's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Medistim ASA reports annually and quarterly.Medistim Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medistim ASA's current stock value. Our valuation model uses many indicators to compare Medistim ASA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medistim ASA competition to find correlations between indicators driving Medistim ASA's intrinsic value. More Info.Medistim ASA is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.63 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medistim ASA is roughly 1.59 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medistim ASA's earnings, one of the primary drivers of an investment's value.Medistim ASA Systematic Risk
Medistim ASA's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Medistim ASA volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was four with a total number of output elements of fifty-seven. The Beta measures systematic risk based on how returns on Medistim ASA correlated with the market. If Beta is less than 0 Medistim ASA generally moves in the opposite direction as compared to the market. If Medistim ASA Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Medistim ASA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Medistim ASA is generally in the same direction as the market. If Beta > 1 Medistim ASA moves generally in the same direction as, but more than the movement of the benchmark.
Medistim ASA November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Medistim ASA help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Medistim ASA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Medistim ASA based on widely used predictive technical indicators. In general, we focus on analyzing Medistim Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Medistim ASA's daily price indicators and compare them against related drivers.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 13.52 | |||
| Value At Risk | (3.64) | |||
| Potential Upside | 5.0 |
Other Information on Investing in Medistim Stock
Medistim ASA financial ratios help investors to determine whether Medistim Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medistim with respect to the benefits of owning Medistim ASA security.